Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases-Reference-Cited by-同舟云学术

Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases

Published:2023-05 Issue: Volume:185 Page:119-130
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Trillo Pamela,Sandoval Josè,Trapani Dario,Nicolò Eleonora,Zagami Paola,Giugliano Federica,Tarantino Paolo,Vivanet Grazia,Ascione Liliana,Friedlaender Alex,Esposito Angela,Criscitiello Carmen,Curigliano Giuseppe

Funder

Ministero della Salute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. WHO classification of tumours of the breast;Lakhani,2019

2. Collective wisdom: lobular carcinoma of the breast;Sledge;Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet,2016

3. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome;Arpino;Breast Cancer Res,2004

4. Frequency, clinicopathologic characteristics, and follow-up of HER2-positive nonpleomorphic invasive lobular carcinoma of the breast;Zhang;Am J Clin Pathol,2020

5. Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: the Singapore experience;Kee;World J Clin Oncol,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-Low Breast Cancer: Now and in the Future;Cancer Research and Treatment;2024-07-15

2. Can 18F-FES PET Improve the Evaluation of 18F-FDG PET in Patients With Metastatic Invasive Lobular Carcinoma?;Clinical Nuclear Medicine;2024-04

3. Development and validation of a model for predicting the risk of cardiovascular events in maintenance hemodialysis patients;Scientific Reports;2024-03-21

4. Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer;Scientific Reports;2024-03-21

5. Targeting Human progesterone receptor (PR), through Pharmacophore- based screening and molecular simulation revealed potent inhibitors against breast cancer;2023-09-26